Atlas Trials

Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19

Clinical trial NCT04367831 · COMPLETED

Trial details

NCT number
NCT04367831
Sponsor
Columbia University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19Venous ThrombosesArterial Thrombosis
Start date
2020-05-02
Primary completion
2021-05-12
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.